Related Experiment Video
Updated: May 15, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53
Sun-Young Lee1, Seok Joon Shin, Ho-Shik Kim
1Department of Biochemistry, College of Medicine, The Catholic University of Korea, Seoul 137-701, Republic of Korea.
Abstract:
Nutlin-3 is a small-molecule antagonist of murine double minute 2 (MDM2) that blocks its binding to p53, leading to an increase in p53 protein levels. The tumor suppressor p53 induces growth arrest or apoptosis in response to genotoxic stress. Along with its growth-suppressive effect, it has been reported that p53 stimulates the mitogen-activated protein kinase (MAPK) pathway via the upregulation of heparin- binding epidermal growth factor-like growth factor (HB-EGF), an epidermal growth factor receptor (EGFR) ligand, and discoidin domain receptor 1 (DDR1), a tyrosine kinase receptor, at the transcription level. In this study, we propose a novel mechanism involved in the p53-induced MAPK activation. Nutlin-3 induced the phosphorylation of EGFR, MAPK/ERK kinase (MEK)1/2 and extracellular signal-regulated kinase (ERK)1/2 in U2OS human osteosarcoma cells harboring wild-type p53. This phosphorylation was completely inhibited by p53 siRNA, but not by pifithrin (PFT)-α, an inhibitor of the trans-criptional activity of p53. While the nutlin-3-induced EGFR phosphorylation was prevented by the inactivation of ERK1/2, the nutlin-3-induced MEK1/2-ERK1/2 phosphorylation was still observed in the cells in which EGFR phosphorylation was inhibited using EGFR siRNA and AG1478, an inhibitor of EGFR tyrosine kinase. Of note, nutlin-3 caused the accumulation of mitochondrial reactive oxygen species (ROS) and this correlated with the mitochondrial translocation of p53. 2,2,6,6-Tetramethyl-1-piperidinyloxy (TEMPO), a ROS scavenger, prevented the phosphorylation of ERK1/2. PFT-μ, which prevented the mitochondrial localization of p53, suppressed ERK1/2 phosphorylation, as well as ROS accumulation. Finally, we analyzed the effect of ERK1/2 activation on nutlin-3-induced apoptosis. The knockdown of MEK1/2 and ERK1/2 activity using U0126, a MEK inhibitor, or siRNAs, resulted in the enhancement of nutlin-3-induced apoptosis. In addition, TEMPO and PFT-μ also promoted nutlin-3-induced apoptosis. Taking the above findings into account, it can be concluded that nutlin-3 activates ERK1/2 prior to EGFR phosphorylation via ROS generation following the mitochondrial translocation of p53 and that nutlin-3-induced ERK1/2 activation may play a role in protecting U2OS cells from p53-dependent apoptosis, constituting a negative feedback loop for p53-induced apoptosis.
Insights
Nutlin-3 activates the ERK1/2 pathway via mitochondrial p53 translocation and ROS generation, independent of EGFR. This activation protects cells from apoptosis, suggesting a negative feedback loop.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Nutlin-3 is a small-molecule antagonist of MDM2, increasing p53 protein levels.
- The tumor suppressor p53 induces growth arrest or apoptosis and can stimulate the MAPK pathway.
- Previous studies suggest p53 upregulates HB-EGF and DDR1, activating MAPK.
Purpose of the Study:
- To investigate a novel mechanism of p53-induced MAPK activation by Nutlin-3.
- To elucidate the role of reactive oxygen species (ROS) and mitochondrial translocation of p53 in this pathway.
- To determine the effect of ERK1/2 activation on Nutlin-3-induced apoptosis.
Main Methods:
- Used U2OS human osteosarcoma cells with wild-type p53.
- Administered Nutlin-3 and employed p53 siRNA, PFT-α, EGFR siRNA, AG1478, TEMPO, and PFT-μ.
- Assessed phosphorylation of EGFR, MEK1/2, and ERK1/2, ROS accumulation, mitochondrial p53 translocation, and apoptosis.
Main Results:
- Nutlin-3 induced EGFR, MEK1/2, and ERK1/2 phosphorylation, dependent on p53 but not p53 transcriptional activity.
- Nutlin-3 caused mitochondrial ROS accumulation and p53 translocation, which were inhibited by TEMPO and PFT-μ.
- Inhibition of MEK1/2 and ERK1/2, or ROS scavenging, enhanced Nutlin-3-induced apoptosis.
Conclusions:
- Nutlin-3 activates ERK1/2 via ROS generation and mitochondrial p53 translocation, preceding EGFR phosphorylation.
- Nutlin-3-induced ERK1/2 activation acts as a negative feedback loop, protecting cells from p53-dependent apoptosis.
- This pathway represents a novel mechanism linking p53, ROS, and MAPK signaling in cancer cells.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway
Regulation of the Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
